The study of ordered mesoporous silica materials has exploded since their discovery by Mobil researchers 20 years ago. The ability to make uniformly sized, porous, and dispersible nanoparticles using colloidal chemistry and evaporation-induced self-assembly has led to many applications of mesoporous silica nanoparticles (MSNPs) as “nanocarriers” for delivery of drugs and other cargos to cells. The exceptionally high surface area of MSNPs, often exceeding 1000 m2/g, and the ability to independently modify pore size and surface chemistry, enables the loading of diverse cargos and cargo combinations at levels exceeding those of other common drug delivery carriers such as liposomes or polymer conjugates. This is because noncovalent electrostatic, hydrogen-bonding, and van der Waals interactions of the cargo with the MSNP internal surface cause preferential adsorption of cargo to the MSNP, allowing loading capacities to surpass the solubility limit of a solution or that achievable by osmotic gradient loading. The ability to independently modify the MSNP surface and interior makes possible engineered biofunctionality and biocompatibility. In this Account, we detail our recent efforts to develop MSNPs as biocompatible nanocarriers (Figure ) that simultaneously display multiple functions including (1) high visibility/contrast in multiple imaging modalities, (2) dispersibility, (3) binding specificity to a particular target tissue or cell type, (4) ability to load and deliver large concentrations of diverse cargos, and (5) triggered or controlled release of cargo. Toward function 1, we chemically conjugated fluorescent dyes or incorporated magnetic nanoparticles to enable in vivo optical or magnetic resonance imaging. For function 2, we have made MSNPs with polymer coatings, charged groups, or supported lipid bilayers, which decrease aggregation and improve stability in saline solutions. For functions 3 and 4, we have enhanced passive bioaccumulation via the enhanced permeability and retention effect by modifying the MSNP surfaces with positively charged polymers. We have also chemically attached ligands to MSNPs that selectively bind to receptors overexpressed in cancer cells. We have used encapsulation of MSNPs within reconfigurable supported lipid bilayers to develop new classes of responsive nanocarriers that actively interact with the target cell. Toward function 4, we exploit the high surface area and tailorable surface chemistry of MSNPs to retain hydrophobic drugs. Finally, for function 5, we have engineered dynamic behaviors by incorporating molecular machines within or at the entrances of MSNP pores and by using ligands, polymers, or lipid bilayers. These provide a means to seal-in and retain cargo and to direct MSNP interactions with and internalization by target cells. Application of MSNPs as nanocarriers requires biocompatibility and low toxicity. Here the intrinsic porosity of the MSNP surface reduces the extent of hydrogen bonding or electrostatic interactions with cell membranes as does surface coati...

We have developed structure/toxicity relationships for amorphous silica nanoparticles (NPs) synthesized through low temperature, colloidal (e.g. Stöber silica) or high temperature pyrolysis (e.g. fumed silica) routes. Through combined spectroscopic and physical analyses, we have determined the state of aggregation, hydroxyl concentration, relative proportion of strained and unstrained siloxane rings, and potential to generate hydroxyl radicals for Stöber and fumed silica NPs with comparable primary particle sizes (16-nm in diameter). Based on erythrocyte hemolytic assays and assessment of the viability and ATP levels in epithelial and macrophage cells, we discovered for fumed silica an important toxicity relationship to post-synthesis thermal annealing or environmental exposure, whereas colloidal silicas were essentially non-toxic under identical treatment conditions. Specifically, we find for fumed silica a positive correlation of toxicity with hydroxyl concentration and its potential to generate reactive oxygen species (ROS) and cause red blood cell hemolysis. We propose fumed silica toxicity stems from its intrinsic population of strained three-membered rings (3MRs) along with its chain-like aggregation and hydroxyl content. Hydrogen-bonding and electrostatic interactions of the silanol surfaces of fumed silica aggregates with the extracellular plasma membrane cause membrane perturbations sensed by the Nalp3 inflammasome, whose subsequent activation leads to secretion of the cytokine IL-1β. Hydroxyl radicals generated by the strained 3MRs in fumed silica but largely absent in colloidal silicas may contribute to the inflammasome activation. Formation of colloidal silica into aggregates mimicking those of fumed silica had no effect on cell viability or hemolysis. This study emphasizes that not all amorphous silica is created equal and that the unusual toxicity of fumed silica compared to colloidal silica derives from its framework and surface chemistry along with its fused chain-like morphology established by high temperature synthesis (>1300°C) and rapid thermal quenching.

A key challenge for improving the efficacy of passive drug delivery to tumor sites by a nanocarrier is to limit reticuloendothelial system (RES) uptake and to maximize the enhanced permeability and retention (EPR) effect. We demonstrate that size reduction and surface functionalization of mesoporous silica nanoparticles (MSNP) with a polyethyleneimine-polyethylene glycol (PEI-PEG) co-polymer reduces particle opsonization while enhancing the passive delivery of monodispersed, 50 nm doxorubicin-laden MSNP to a human squamous carcinoma xenograft in nude mice after intravenous injection. Using near infrared (NIR) fluorescence imaging and elemental Si analysis, we demonstrate passive accumulation of ∼12% of the injected particle load at the tumor site, where there is effective cellular uptake and the delivery of doxorubicin to KB-31 cells. This was accompanied by the induction of apoptosis and an enhanced rate of tumor shrinking compared to free doxorubicin. The improved drug delivery was accompanied by a significant reduction in systemic side effects such as animal weight loss as well as reduced liver and renal injury. These results demonstrate that it is possible to achieve effective passive tumor targeting by MSNP size reduction as well as introducing steric hindrance and electrostatic repulsion through coating with a co-polymer. Further endowment of this multifunctional drug delivery platform with targeting ligands and nanovalves may further enhance cell-specific targeting and on-demand release.

The exocytosis of phosphonate modified mesoporous silica nanoparticles (P‐MSNs) is demonstrated and lysosomal exocytosis is identified as the mechanism responsible for this event. Regulation of P‐MSN exocytosis can be achieved by inhibiting or accelerating lysosomal exocytosis. Slowing down P‐MSN exocytosis enhances the drug delivery effect of CPT‐loaded P‐MSNs by improving cell killing.

the systems described so far require UV-Vis light which limits their applications. Two-Photon Excitation (TPE) in the near-infrared region is a promising alternative to UV-vis light due to the many advantages TPE provides such as three dimensional spatial resolution, lower scattering losses, and deeper penetration in tissues.[ 16 ] Very few TPE-triggered MSN-based drug delivery systems have been described in the literature, [ 17,18 ] and only two very recent examples were reported with cytotoxic drug delivery in cancer cells. The fi rst example is based on coumarin cleavage and needed very high material concentration (1 mg mL −1 ) in cells and long time of irradiation (1 h) to observe a cancer cell killing effect.[ 19 ] The second was described by us and concerned nanoimpellers reconfi gured for TPE.[ 20 ] The system was effi cient in inducing cancer cell death under TPE. In this communication, we report an alternative MSN-azobenzene-based system with a high specifi c surface area and pore volume for TPE-triggered drug delivery in cancer cells. Furthermore, two-photon fl uorescence imaging in vitro was also performed (see Scheme 1 ). First of all, a novel two-photon paracyclophane-based fl uorophore (CF) possessing a high two-photon absorption cross-section was designed and fully characterized. (see the Supporting Information). The maximum emission of the fl uorophore was 415 nm in THF, with a quantum yield of 68% suitable for FRET with azobenzene ( Figure 1 ).The silylated fl uorophore (CF) was co-condensed with tetraethoxysilane (TEOS) and cetyltrimethylammonium bromide (CTAB) in basic media to lead to the two-photon fl uorescent MSN (MCF NPs). Mono-triethoxysilylated azobenzene was then grafted on the surface of the nanoparticles (MCF-AZO NPs). Then, the cargo was loaded in the pores of the MCF-AZO NPs. The supramolecular complexation of β-cyclodextrin was performed in ice-cooled conditions, in order to cap the porous surface to lead to the nanovalve (MCF-AZO@βCD NPs). As a control MCM-41 type MSN NPs were functionalized with azobenzene (MSN-AZO NPs) and β-cyclodextrin MSN-AZO@βCD NPs using the same procedure.The characterizations of the MCF NPs after surfactant removal confi rmed the monodispersity and mesoporosity of Drug Delivery